ECSP11010876A - Combinación farmacéutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol - Google Patents

Combinación farmacéutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol

Info

Publication number
ECSP11010876A
ECSP11010876A EC2011010876A ECSP11010876A ECSP11010876A EC SP11010876 A ECSP11010876 A EC SP11010876A EC 2011010876 A EC2011010876 A EC 2011010876A EC SP11010876 A ECSP11010876 A EC SP11010876A EC SP11010876 A ECSP11010876 A EC SP11010876A
Authority
EC
Ecuador
Prior art keywords
paracetamol
phenyl
diol
pharmaceutical combination
dimethylaminometil
Prior art date
Application number
EC2011010876A
Other languages
English (en)
Inventor
Klaus Schiene
Funke Petra Blows
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40328601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP11010876(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of ECSP11010876A publication Critical patent/ECSP11010876A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una combinación formada por (a) por lo menos un componente 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y (b) el paracetamol o un derivado del mismo; una combinación farmacéutica y una forma de dosificación que contiene dicha combinación así como un método para tratar uno o más de dolor y osteoartritis en un mamífero, caracterizada porque los componentes (a) y (b) se administran simultánea o sucesivamente a dicho mamífero, dicho componente (a) puede administrarse antes o después del componente (b) y dichos componentes (a) o (b) se administran al mamífero por la misma vía o por vías diferentes.
EC2011010876A 2008-09-05 2011-03-04 Combinación farmacéutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol ECSP11010876A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08015621 2008-09-05

Publications (1)

Publication Number Publication Date
ECSP11010876A true ECSP11010876A (es) 2011-04-29

Family

ID=40328601

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2011010876A ECSP11010876A (es) 2008-09-05 2011-03-04 Combinación farmacéutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol

Country Status (19)

Country Link
US (1) US20100069501A1 (es)
EP (1) EP2331087A1 (es)
JP (1) JP2012501985A (es)
KR (1) KR20110059634A (es)
CN (1) CN102202660A (es)
AR (1) AR073277A1 (es)
AU (1) AU2009289824A1 (es)
BR (1) BRPI0918566A2 (es)
CA (1) CA2735855A1 (es)
CL (1) CL2011000387A1 (es)
CO (1) CO6341552A2 (es)
EC (1) ECSP11010876A (es)
IL (1) IL211395A0 (es)
MX (1) MX2011002430A (es)
NZ (1) NZ591419A (es)
PE (1) PE20110799A1 (es)
RU (1) RU2011112443A (es)
WO (1) WO2010025930A1 (es)
ZA (1) ZA201101669B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9855286B2 (en) 2012-05-18 2018-01-02 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component
US20130310435A1 (en) * 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
US9320729B2 (en) 2012-05-18 2016-04-26 Gruenenthal Gmbh Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative
US20130310385A1 (en) 2012-05-18 2013-11-21 Gruenenthal Gmbh Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122004000032I2 (de) * 1991-09-06 2006-02-09 Mcneilab Inc Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
EP1156855A1 (en) * 1999-03-01 2001-11-28 Ortho-McNeil Pharmaceutical, Inc. Composition comprising a tramadol material and a selective cox-2 inhibitor drug
ATE391498T1 (de) * 2002-11-22 2008-04-15 Gruenenthal Gmbh Verwendung von (1rs,3rs,6rs)-6- dimethylaminomethyl-1-(3-methoxy-phenyl)- cyclohexan-1,3-diol zur behandlung von entzündungsschmerz

Also Published As

Publication number Publication date
CL2011000387A1 (es) 2011-06-17
PE20110799A1 (es) 2011-11-10
AU2009289824A1 (en) 2010-03-11
EP2331087A1 (en) 2011-06-15
ZA201101669B (en) 2011-11-30
AR073277A1 (es) 2010-10-28
BRPI0918566A2 (pt) 2016-02-10
MX2011002430A (es) 2011-04-05
RU2011112443A (ru) 2012-10-10
KR20110059634A (ko) 2011-06-02
CN102202660A (zh) 2011-09-28
CO6341552A2 (es) 2011-11-21
US20100069501A1 (en) 2010-03-18
JP2012501985A (ja) 2012-01-26
NZ591419A (en) 2011-11-25
CA2735855A1 (en) 2010-03-11
IL211395A0 (en) 2011-05-31
WO2010025930A1 (en) 2010-03-11

Similar Documents

Publication Publication Date Title
AR117613A2 (es) Combinación farmacéutica
ECSP19047259A (es) Combinación farmacéutica para el tratamiento del dolor
ECSP17013617A (es) “combinación farmacéutica que comprende 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y nsaid”
PY1041126A (es) Composiciones de corticosteroides de administración oral
UY35210A (es) Inhibidores de autotaxina
GT201500021A (es) Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b
MX350046B (es) Tratamientos para trastornos gastrointestinales.
MX2016000271A (es) Metodos para el tratamiento de la esofagitis eosinofilica mediante la administracion de un inhibidor de il-4r.
MX2017009561A (es) Metodos de purificacion de cannabinoides, composiciones y kits de los mismos.
CL2015001389A1 (es) Composiciones y compuestos antihelmínticos y métodos para usarlos.
ECSP14013315A (es) Inhibidores de aplicación viral
MX377089B (es) Uso de una proteína angiopoyetina modificada en la preparación de un medicamento para prevenir o tratar la malaria cerebral.
UY32776A (es) Compuestos de imidazopirazinas sustituidas para el tratamiento de enfermedades parasitarias,composiciones farmacéuticas que los contienen y aplicación.
CR11418A (es) Trans-clomifeno para el sindrome metabolico
UY31922A (es) Compuestos
ECSP13013012A (es) Análogos del ácido epoxieicosatrienoicos y métodos de preparación
CO6341550A2 (es) Combinacion farmaceutica que contiene el 6 - dimetilaminometil - 1 - (3-metoxi-fenil) - ciclohexano - 1,3 - diol y un nsaid.
ECSP11010876A (es) Combinación farmacéutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y paracetamol
AR077987A1 (es) Combinacion farmaceutica que comprende 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol o 6-dimetilaminometil-1-(3-hidroxifenil)-ciclohexano-1,3-diol y un antiepileptico
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
CO7170180A2 (es) Composición farmacéutica inyectable de dexketoprofeno y tramadol
ES2721922T3 (es) Tratamiento o prevención del daño neuronal no inflamatorio por traumatismo cerebral e ictus utilizando mentol, linalool y/o icilina
ES2485540B1 (es) Compuestos útiles en el tratamiento de la aciduría metilmalónica
MX2015017136A (es) Composicion para la administracion oral de magnesio, en asociacion con una composicion para tratar la diabetes tipo 2 o las complicaciones de la misma.
GT201500189A (es) Inhibidores de autotaxina